Ramanan Laxminarayan

From Bharatpedia, an open encyclopedia
Information red.svg
Scan the QR code to donate via UPI
Dear reader, We need your support to keep the flame of knowledge burning bright! Our hosting server bill is due on June 1st, and without your help, Bharatpedia faces the risk of shutdown. We've come a long way together in exploring and celebrating our rich heritage. Now, let's unite to ensure Bharatpedia continues to be a beacon of knowledge for generations to come. Every contribution, big or small, makes a difference. Together, let's preserve and share the essence of Bharat.

Thank you for being part of the Bharatpedia family!
Please scan the QR code on the right click here to donate.

0%

   

transparency: ₹0 raised out of ₹100,000 (0 supporter)



Ramanan Laxminarayan Ph.D., M.P.H is an economist and an epidemiologist. He is founder and director of the Center for Disease Dynamics, Economics & Policy (CDDEP) in Washington, D.C. and senior research scholar at Princeton University, an affiliate professor at the University of Washington. His research on epidemiological models of infectious diseases and economic analysis of drug resistance on public health gets attention from leaders and policymakers worldwide.[1] He served on the President Obama's Council of Advisors on Science and Technology’s antimicrobial resistance working group. He is also a voting member of the U.S. Presidential Advisory Council on Combating Antimicrobial Resistance.[2] He is a chairperson of the Global Antibiotic Research and Development Partnership (GARDP), a not-for-profit organization created by the World Health Organization along with Drugs for Neglected Diseases Initiative (DNDi).[3][4]

Laxminarayan was a key architect of the Affordable Medicines Facility-malaria (AMFm), an innovative financing mechanism to provide affordable, effective antimalarial drugs worldwide.[5] The idea emerged from an Institute of Medicine panel chaired by economist Kenneth Arrow that called for global subsidies to ensure that artemisinin-based antimalarials were introduced to crowd out monotherapies that would result in resistance.[6] Laxminarayan served on that panel and subsequently worked extensively on the design of the subsidy mechanism.[7][8]  AMFm was launched in 2008 with a commitment from British Prime Minister Gordon Brown.[9]

He is a leading global expert on understanding of antibiotic resistance as a problem of managing a shared global resource. Through his prolific research, active public outreach and sustained policy engagement, Laxminarayan played a central role in bringing the issue of drug resistance to the attention of leaders and policymakers worldwide and to the United Nations General Assembly in September 2016.[10][11]  His TED talk on antibiotic resistance which helped bring attention to this issue has been viewed more than a million times.[12]  

During the Obama Administration, Laxminarayan served on the U.S. President’s Council of Advisors on Science and Technology’s antimicrobial resistance working group.[13] He was subsequently appointed a voting member of the U.S. Presidential Advisory Council on Combating Antimicrobial Resistance in 2016.[14]

In 2012, Laxminarayan created the Immunization Technical Support Unit that supports the immunization program of the Ministry of Health and Family Welfare of the Government of India and which is credited with helping rapidly improve vaccination coverage and introduction of four new vaccines.[15] He is a series editor of the Disease Control Priorities for Developing Countries, 3rd edition.[16]

Selected awards and honors[edit]

Distinguished Alumnus, Academia and Research, Birla Institute of Technology and Science, Pilani, 2019[17]

Distinguished Alumnus, University of Washington, Seattle, 2020[18]

Ella Pringle Keynote Lecture Medal, Royal College of Physicians of Edinburgh 2018[19]

Winter Lecture, 2015, University of Edinburgh[20]

BP Koirala Memorial Oration, BP Koirala Institute of Health Sciences, Dharan, 2019[21]

References[edit]

  1. ↑ "What India Needs to Fight the Virus". The New York Times. March 27, 2020. Retrieved 26 April 2020.
  2. ↑ "Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria". Assistant Secretary for Health Department of Health and Human Services Washington, DC. Retrieved 26 April 2020.
  3. ↑ Maxmen, Amy (July 7, 2017). "Untreatable Gonorrhea on the Rise Worldwide". Nature magazine. Retrieved 26 April 2020.
  4. ↑ "C V OF RAMANAN LAXMINARAYAN" (PDF). https://cddep.org/. Retrieved 27 April 2020. {{cite web}}: External link in |website= (help)
  5. ↑ Laxminarayan, Ramanan; Gelband, Hellen (July 2009). "A global subsidy: key to affordable drugs for malaria?". Health Affairs (Project Hope). 28 (4): 949–961. doi:10.1377/hlthaff.28.4.949. ISSN 1544-5208. PMID 19597193.
  6. ↑ Medicine, Institute of (2004-07-20). Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. ISBN 978-0-309-09218-0.
  7. ↑ Laxminarayan, Ramanan; Parry, Ian W. H.; Smith, David L.; Klein, Eili Y. (2010-05-01). "Should new antimalarial drugs be subsidized?". Journal of Health Economics. 29 (3): 445–456. doi:10.1016/j.jhealeco.2010.03.002. ISSN 0167-6296.
  8. ↑ Laxminarayan, Ramanan; Arrow, Kenneth; Jamison, Dean; Bloom, Barry R. (2012-11-02). "From Financing to Fevers: Lessons of an Antimalarial Subsidy Program". Science. 338 (6107): 615–616. doi:10.1126/science.1231010. ISSN 0036-8075. PMID 23118173.
  9. ↑ Laxminarayan, Ramanan; Gelband, Hellen (July 2009). "A Global Subsidy: Key To Affordable Drugs For Malaria?". Health Affairs. 28 (4): 949–961. doi:10.1377/hlthaff.28.4.949. ISSN 0278-2715.
  10. ↑ Jørgensen, Peter S.; Wernli, Didier; Carroll, Scott P.; Dunn, Robert R.; Harbarth, Stephan; Levin, Simon A.; So, Anthony D.; Schlüter, Maja; Laxminarayan, Ramanan (2016-09-08). "Use antimicrobials wisely". Nature News. 537 (7619): 159. doi:10.1038/537159a.
  11. ↑ Laxminarayan, Ramanan; Sridhar, Devi; Blaser, Martin; Wang, Minggui; Woolhouse, Mark (2016-08-26). "Achieving global targets for antimicrobial resistance". Science. 353 (6302): 874–875. doi:10.1126/science.aaf9286. hdl:20.500.11820/34211550-a24c-4a47-a0f0-128c404f2176. ISSN 0036-8075. PMID 27540009.
  12. ↑ Laxminarayan, Ramanan, The coming crisis in antibiotics, retrieved 2020-08-12
  13. ↑ Members of PCAST Antibiotic Resistance Working Group
  14. ↑ Health (ASH), Assistant Secretary for (2016-02-08). "Voting Member (SGE): Ramanan Laxminarayan, PhD, MPH". HHS.gov. Retrieved 2020-08-12.
  15. ↑ Delhi (2015-03-23). "Health Minister Shri J P Nadda launches Media Campaign for 'Mission Indradhanush' Seeks cooperation of various stakeholders in creating awareness and generating support for full immunization of all children". Business Standard India. Retrieved 2020-08-12.
  16. ↑ "Ramanan Laxminarayan | DCP3". dcp-3.org. Retrieved 2020-08-12.
  17. ↑ Distinguished Alumnus, Academia and Research, Birla Institute of Technology and Science, Pilani [1]
  18. ↑ "Ramanan Laxminarayan - Our 2020 Distinguished Alumnus| Department of Economics| University of Washington". econ.washington.edu. Retrieved 2020-08-12.
  19. ↑ "https://twitter.com/rcpedin/status/1007233150894903296". Twitter. Retrieved 2020-08-12. {{cite web}}: External link in |title= (help)
  20. ↑ "Further Seminars and Events". The University of Edinburgh. Retrieved 2020-08-12.
  21. ↑ Ramanan Laxminarayan received the BP Koirala Medal and delivered the BP Koirala Memorial Oration in honor of Nepal’s first democratically elected Prime Minister.[2]
Retrieved from "https://en.bharatpedia.org/index.php?title=Ramanan_Laxminarayan&oldid=229596"